Why It Matters
The surge underscores growing demand for private health and income‑protection products, pressuring insurers to enhance service speed and digital capabilities.
Key Takeaways
- •Health payouts hit $66 M, driven by musculoskeletal and cancer claims
- •Income‑protection claims up 4.5%, total $18 M, reflecting higher volumes
- •Life‑insurance claims paid at 95% rate, exceeding $6.6 M
- •Exeter invests in tech and adviser expertise to speed claim processing
Pulse Analysis
The Exeter’s 2025 claim experience reveals a broader trend in the UK protection market: health‑related payouts are accelerating as consumers seek private coverage for chronic and serious conditions. Musculoskeletal disorders and cancer, which together dominate the claim landscape, reflect an aging workforce and heightened awareness of out‑of‑pocket medical costs. Insurers that can price these risks accurately while offering seamless digital claim journeys are poised to capture market share, especially as traditional NHS capacity faces pressure.
Income‑protection products also showed robust growth, with payouts climbing 12% to an estimated $18 million. The average claimant age of 37 and claim duration of roughly 70‑74 weeks illustrate the product’s appeal to younger professionals seeking long‑term income security. This demographic shift pushes providers to refine underwriting models and leverage data analytics to predict claim frequency, ensuring profitability without compromising the promised coverage.
Beyond the numbers, The Exeter’s emphasis on technology and adviser support signals an industry‑wide pivot toward faster, more personalized service. By integrating AI‑driven triage tools and real‑time communication platforms, insurers can reduce processing times and improve member satisfaction. For advisers, deeper product knowledge combined with digital tools enhances their role as trusted guides during stressful claim events, reinforcing the value proposition of protection products in a competitive market.
The Exeter pays £71m as health claims surge

Comments
Want to join the conversation?
Loading comments...